Bristol-Myers Squibb Company (BMY)
USD 56.84
(-1.41%)
USD 56.84
(-1.41%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.66 Billion USD | 13.81% |
| 2022 | 2.33 Billion USD | 11.65% |
| 2021 | 2.09 Billion USD | 1.01% |
| 2020 | 2.07 Billion USD | -51.69% |
| 2019 | 4.29 Billion USD | 259.25% |
| 2018 | 1.19 Billion USD | 2.49% |
| 2017 | 1.16 Billion USD | -6.04% |
| 2016 | 1.24 Billion USD | 1.64% |
| 2015 | 1.22 Billion USD | -21.73% |
| 2014 | 1.56 Billion USD | 4.14% |
| 2013 | 1.49 Billion USD | -9.6% |
| 2012 | 1.65 Billion USD | 19.73% |
| 2011 | 1.38 Billion USD | 14.95% |
| 2010 | 1.2 Billion USD | -14.79% |
| 2009 | 1.41 Billion USD | -19.94% |
| 2008 | 1.76 Billion USD | -18.36% |
| 2007 | 2.16 Billion USD | 3.99% |
| 2006 | 2.07 Billion USD | 0.92% |
| 2005 | 2.06 Billion USD | 12.57% |
| 2004 | 1.83 Billion USD | 14.3% |
| 2003 | 1.6 Billion USD | 1.78% |
| 2002 | 1.57 Billion USD | 5.78% |
| 2001 | 1.48 Billion USD | -18.79% |
| 2000 | 1.83 Billion USD | -13.88% |
| 1999 | 2.12 Billion USD | 13.51% |
| 1998 | 1.87 Billion USD | 4.11% |
| 1997 | 1.79 Billion USD | 7.79% |
| 1996 | 1.66 Billion USD | 15.02% |
| 1995 | 1.45 Billion USD | 3.87% |
| 1994 | 1.39 Billion USD | 5.67% |
| 1993 | 1.32 Billion USD | -11.28% |
| 1992 | 1.49 Billion USD | 2.69% |
| 1991 | 1.45 Billion USD | 6.22% |
| 1990 | 1.36 Billion USD | 19.93% |
| 1989 | 1.13 Billion USD | 9.1% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 3.07 Billion USD | 3.08% |
| 2024 Q3 | 3.33 Billion USD | 8.29% |
| 2024 Q1 | 2.98 Billion USD | 12.13% |
| 2023 Q4 | 2.66 Billion USD | 9.28% |
| 2023 Q3 | 2.43 Billion USD | 3.05% |
| 2023 Q2 | 2.36 Billion USD | -9.25% |
| 2023 FY | 2.66 Billion USD | 13.81% |
| 2023 Q1 | 2.6 Billion USD | 11.37% |
| 2022 FY | 2.33 Billion USD | 11.65% |
| 2022 Q1 | 2.1 Billion USD | 0.43% |
| 2022 Q2 | 2.14 Billion USD | 1.81% |
| 2022 Q3 | 2.07 Billion USD | -3.17% |
| 2022 Q4 | 2.33 Billion USD | 12.78% |
| 2021 Q3 | 2.16 Billion USD | 1.22% |
| 2021 Q2 | 2.13 Billion USD | 9.42% |
| 2021 FY | 2.09 Billion USD | 1.01% |
| 2021 Q1 | 1.95 Billion USD | -5.83% |
| 2021 Q4 | 2.09 Billion USD | -3.14% |
| 2020 Q2 | 2.38 Billion USD | -15.94% |
| 2020 Q4 | 2.07 Billion USD | 6.41% |
| 2020 Q3 | 1.94 Billion USD | -18.25% |
| 2020 Q1 | 2.83 Billion USD | -33.94% |
| 2020 FY | 2.07 Billion USD | -51.69% |
| 2019 Q4 | 4.29 Billion USD | 260.15% |
| 2019 Q1 | 1.28 Billion USD | 7.36% |
| 2019 Q2 | 1.3 Billion USD | 1.95% |
| 2019 FY | 4.29 Billion USD | 259.25% |
| 2019 Q3 | 1.19 Billion USD | -8.87% |
| 2018 Q2 | 1.24 Billion USD | 0.89% |
| 2018 Q1 | 1.23 Billion USD | 5.57% |
| 2018 FY | 1.19 Billion USD | 2.49% |
| 2018 Q4 | 1.19 Billion USD | -6.79% |
| 2018 Q3 | 1.28 Billion USD | 3.22% |
| 2017 Q4 | 1.16 Billion USD | -6.72% |
| 2017 Q3 | 1.25 Billion USD | 2.71% |
| 2017 Q2 | 1.21 Billion USD | -12.07% |
| 2017 Q1 | 1.38 Billion USD | 11.52% |
| 2017 FY | 1.16 Billion USD | -6.04% |
| 2016 Q1 | 1.33 Billion USD | 9.42% |
| 2016 Q2 | 1.43 Billion USD | 7.56% |
| 2016 Q3 | 1.48 Billion USD | 3.13% |
| 2016 Q4 | 1.24 Billion USD | -16.26% |
| 2016 FY | 1.24 Billion USD | 1.64% |
| 2015 Q2 | 1.3 Billion USD | -9.26% |
| 2015 Q3 | 1.13 Billion USD | -13.34% |
| 2015 Q4 | 1.22 Billion USD | 8.05% |
| 2015 FY | 1.22 Billion USD | -21.73% |
| 2015 Q1 | 1.43 Billion USD | -7.88% |
| 2014 FY | 1.56 Billion USD | 4.14% |
| 2014 Q1 | 1.65 Billion USD | 10.48% |
| 2014 Q2 | 1.66 Billion USD | 0.66% |
| 2014 Q3 | 1.56 Billion USD | -6.06% |
| 2014 Q4 | 1.56 Billion USD | -0.32% |
| 2013 Q2 | 1.78 Billion USD | -0.34% |
| 2013 Q1 | 1.79 Billion USD | 8.09% |
| 2013 FY | 1.49 Billion USD | -9.6% |
| 2013 Q4 | 1.49 Billion USD | -8.66% |
| 2013 Q3 | 1.64 Billion USD | -8.12% |
| 2012 Q1 | 1.46 Billion USD | 5.71% |
| 2012 Q3 | 1.69 Billion USD | 11.57% |
| 2012 Q4 | 1.65 Billion USD | -2.36% |
| 2012 FY | 1.65 Billion USD | 19.73% |
| 2012 Q2 | 1.52 Billion USD | 3.96% |
| 2011 Q3 | 1.35 Billion USD | -9.05% |
| 2011 Q4 | 1.38 Billion USD | 1.99% |
| 2011 FY | 1.38 Billion USD | 14.95% |
| 2011 Q1 | 1.32 Billion USD | 9.8% |
| 2011 Q2 | 1.49 Billion USD | 12.86% |
| 2010 Q1 | 1.28 Billion USD | -9.13% |
| 2010 FY | 1.2 Billion USD | -14.79% |
| 2010 Q4 | 1.2 Billion USD | -12.05% |
| 2010 Q3 | 1.36 Billion USD | 8.22% |
| 2010 Q2 | 1.26 Billion USD | -1.48% |
| 2009 Q4 | 1.41 Billion USD | -22.53% |
| 2009 Q1 | 1.73 Billion USD | -1.7% |
| 2009 Q2 | 1.78 Billion USD | 2.59% |
| 2009 FY | 1.41 Billion USD | -19.94% |
| 2009 Q3 | 1.82 Billion USD | 2.47% |
| 2008 Q1 | 2.33 Billion USD | 8.05% |
| 2008 Q3 | 2.05 Billion USD | -4.68% |
| 2008 Q2 | 2.15 Billion USD | -7.71% |
| 2008 FY | 1.76 Billion USD | -18.36% |
| 2008 Q4 | 1.76 Billion USD | -14.11% |
| 2007 Q1 | 2.09 Billion USD | 0.82% |
| 2007 Q2 | 2.22 Billion USD | 6.11% |
| 2007 Q3 | 2.26 Billion USD | 2.02% |
| 2007 Q4 | 2.16 Billion USD | -4.72% |
| 2007 FY | 2.16 Billion USD | 3.99% |
| 2006 Q1 | 2.14 Billion USD | 4.22% |
| 2006 FY | 2.07 Billion USD | 0.92% |
| 2006 Q3 | 2.29 Billion USD | 4.17% |
| 2006 Q2 | 2.2 Billion USD | 2.7% |
| 2006 Q4 | 2.07 Billion USD | -9.49% |
| 2005 FY | 2.06 Billion USD | 12.57% |
| 2005 Q1 | 1.92 Billion USD | 5.19% |
| 2005 Q2 | 1.99 Billion USD | 3.53% |
| 2005 Q3 | 2.05 Billion USD | 3.01% |
| 2005 Q4 | 2.06 Billion USD | 0.34% |
| 2004 Q1 | 1.64 Billion USD | 2.75% |
| 2004 FY | 1.83 Billion USD | 14.3% |
| 2004 Q4 | 1.83 Billion USD | 3.68% |
| 2004 Q3 | 1.76 Billion USD | 5.44% |
| 2004 Q2 | 1.67 Billion USD | 1.76% |
| 2003 Q4 | 1.6 Billion USD | -6.97% |
| 2003 FY | 1.6 Billion USD | 1.78% |
| 2003 Q1 | 1.53 Billion USD | -2.48% |
| 2003 Q2 | 1.7 Billion USD | 10.89% |
| 2003 Q3 | 1.72 Billion USD | 1.18% |
| 2002 Q1 | 1.55 Billion USD | 4.77% |
| 2002 Q2 | 1.64 Billion USD | 5.65% |
| 2002 FY | 1.57 Billion USD | 5.78% |
| 2002 Q3 | 1.73 Billion USD | 5.41% |
| 2002 Q4 | 1.57 Billion USD | -9.34% |
| 2001 Q4 | 1.48 Billion USD | -10.96% |
| 2001 FY | 1.48 Billion USD | -18.79% |
| 2001 Q3 | 1.67 Billion USD | -12.52% |
| 2001 Q2 | 1.9 Billion USD | -1.5% |
| 2001 Q1 | 1.93 Billion USD | 5.84% |
| 2000 FY | 1.83 Billion USD | -13.88% |
| 2000 Q1 | 2.04 Billion USD | -3.76% |
| 2000 Q2 | 2.01 Billion USD | -1.42% |
| 2000 Q3 | 1.85 Billion USD | -8.18% |
| 2000 Q4 | 1.83 Billion USD | -1.13% |
| 1999 Q3 | 2.05 Billion USD | 0.39% |
| 1999 Q4 | 2.12 Billion USD | 3.61% |
| 1999 FY | 2.12 Billion USD | 13.51% |
| 1999 Q2 | 2.04 Billion USD | 4.55% |
| 1999 Q1 | 1.95 Billion USD | 4.38% |
| 1998 Q2 | 1.81 Billion USD | -1.63% |
| 1998 FY | 1.87 Billion USD | 4.11% |
| 1998 Q1 | 1.84 Billion USD | 2.39% |
| 1998 Q3 | 1.77 Billion USD | -2.04% |
| 1998 Q4 | 1.87 Billion USD | 5.52% |
| 1997 FY | 1.79 Billion USD | 7.79% |
| 1997 Q3 | 1.81 Billion USD | 0.61% |
| 1997 Q4 | 1.79 Billion USD | -1.1% |
| 1997 Q1 | 1.73 Billion USD | 4.13% |
| 1997 Q2 | 1.8 Billion USD | 4.03% |
| 1996 Q3 | 1.54 Billion USD | -0.71% |
| 1996 Q1 | 1.48 Billion USD | 2.27% |
| 1996 Q2 | 1.55 Billion USD | 4.78% |
| 1996 FY | 1.66 Billion USD | 15.02% |
| 1996 Q4 | 1.66 Billion USD | 8.1% |
| 1995 Q4 | 1.45 Billion USD | 0.9% |
| 1995 Q2 | 1.47 Billion USD | -1.08% |
| 1995 Q1 | 1.48 Billion USD | 6.51% |
| 1995 FY | 1.45 Billion USD | 3.87% |
| 1995 Q3 | 1.43 Billion USD | -2.31% |
| 1994 FY | 1.39 Billion USD | 5.67% |
| 1994 Q1 | 1.38 Billion USD | 4.77% |
| 1994 Q2 | 1.41 Billion USD | 2.24% |
| 1994 Q4 | 1.39 Billion USD | 0.36% |
| 1994 Q3 | 1.39 Billion USD | -1.69% |
| 1993 Q3 | 1.46 Billion USD | 0.41% |
| 1993 Q1 | 1.42 Billion USD | -4.63% |
| 1993 Q4 | 1.32 Billion USD | -9.76% |
| 1993 Q2 | 1.45 Billion USD | 2.67% |
| 1993 FY | 1.32 Billion USD | -11.28% |
| 1992 Q1 | 1.55 Billion USD | 7.24% |
| 1992 FY | 1.49 Billion USD | 2.69% |
| 1992 Q4 | 1.49 Billion USD | -8.7% |
| 1992 Q3 | 1.63 Billion USD | 0.74% |
| 1992 Q2 | 1.62 Billion USD | 4.11% |
| 1991 FY | 1.45 Billion USD | 6.22% |
| 1991 Q1 | 1.38 Billion USD | 1.46% |
| 1991 Q2 | 1.43 Billion USD | 3.82% |
| 1991 Q3 | 1.47 Billion USD | 2.29% |
| 1991 Q4 | 1.45 Billion USD | -1.43% |
| 1990 Q2 | 1.24 Billion USD | 6.26% |
| 1990 FY | 1.36 Billion USD | 19.93% |
| 1990 Q1 | 1.16 Billion USD | 2.46% |
| 1990 Q3 | 1.3 Billion USD | 5.16% |
| 1990 Q4 | 1.36 Billion USD | 4.75% |
| 1989 FY | 1.13 Billion USD | 9.1% |
| 1989 Q4 | 1.13 Billion USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AbbVie Inc. | 4.09 Billion USD | 35.057% |
| Bristol-Myers Squibb Company Ce | 2.66 Billion USD | 0.0% |
| Johnson & Johnson | 11.18 Billion USD | 76.192% |
| Eli Lilly and Company | 5.77 Billion USD | 53.887% |
| Merck & Co., Inc. | 6.35 Billion USD | 58.131% |
| Novartis AG | 5.91 Billion USD | 54.981% |
| Organon & Co. | 1.31 Billion USD | -102.433% |
| Pfizer Inc. | 10.18 Billion USD | 73.874% |